• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAB

PATRYS LIMITED

3.13% ! 3.3¢
Market Cap $21.33M  !

Patrys Limited is focused on the development of its deoxymab platform of cell-penetrating... Patrys Limited is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company’s deoxymab platform is based on the deoxymab 3E10 antibody that is identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus (SLE). It has developed two humanized forms of deoxymab 3E10, both have improved activity over the original deoxymab 3E10 antibody. PAT-DX1 is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, while PAT-DX3 is a full-sized IgG antibody. In a range of pre-clinical studies, PAT-DX1 has shown an ability to kill cancer cells in cell models, human tumor explants, xenograft and orthotopic models. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. This allows specific delivery of cancer drugs to multiple types of cancer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAB 20/05/26 1 403
20/05/26 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  403 
PAB 15/05/26 0 158
15/05/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  158 
PAB 06/05/26 1 428
06/05/26 Last post  mattyedw Comments Created with Sketch.  1  Views Created with Sketch.  428 
PAB 06/05/26 0 153
06/05/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  153 
PAB 04/05/26 2 760
04/05/26 Last post  mattyedw Comments Created with Sketch.  2  Views Created with Sketch.  760 
PAB 29/04/26 0 142
29/04/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  142 
PAB 29/04/26 0 137
29/04/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  137 
PAB 27/04/26 29 5.6K
27/04/26 Last post  LadyBug26 Comments Created with Sketch.  29  Views Created with Sketch.  5.6K 

See All Discussions arrow Created with Sketch.

Timeline

Patrys advances RLS-2202 toward Phase 1 Clinical Trial
20 May 09:31
 
Appendix 4C - Quarterly - 31 March 2026 - Updated
15 May 18:20
 
Letter to Shareholders - General Meeting
06 May 08:17
 
Notice of General Meeting/Proxy Form
06 May 08:17
 
Appendix 4C - Quarterly - 31 March 2026
30 Apr 09:13
 
Cleansing Notice
29 Apr 08:48
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Last
3.3¢
Change
0.001(3.13%)
Mkt cap ! $21.33M
Open High Low Volume
3.4¢ 3.4¢ 3.3¢ 112.2K

Buyers (Bids)

Vol. Price($)
447 3.3¢
 

Sellers (Offers)

Price($) Vol.
3.4¢ 41367
Last trade - 12.06pm 20/05/2026 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.